HANSON & DOREMUS INVESTMENT MANAGEMENT – AstraZeneca PLC Transaction History
HANSON & DOREMUS INVESTMENT MANAGEMENT portfolio value:
$961,000
portfolio value
HANSON & DOREMUS INVESTMENT MANAGEMENT quarter portfolio value change:
-17.00%
quarter
AstraZeneca PLC 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.14% | -567 shares | -234K | $54.84 | 17.51K |
| Q2 2022 | share | Decrease | -13.73% | -2.87K shares | -196K | $66.07 | 18.08K |
| Q1 2022 | share | Decrease | -5.17% | -1.14K shares | 103K | $66.34 | 20.96K |
| Q4 2021 | share | Decrease | -0.69% | -154 shares | -49K | $58.47 | 22.10K |
| Q3 2021 | share | Decrease | -9.43% | -2.31K shares | -10K | $60.06 | 22.26K |
| Q2 2021 | share | Increase | +1.82% | 439 shares | 147K | $59.44 | 24.58K |
| Q1 2021 | share | Increase | +0.08% | 20 shares | -6K | $49.34 | 24.14K |
| Q4 2020 | share | Decrease | -1.87% | -459 shares | -141K | $48.68 | 24.12K |
| Q3 2020 | share | Decrease | -5.38% | -1.39K shares | -27K | $53.37 | 24.58K |
| Q2 2020 | share | Decrease | -3.98% | -1.07K shares | 166K | $51.1 | 25.97K |
| Q1 2020 | share | Decrease | -6.97% | -2.02K shares | -242K | $43.15 | 27.05K |
| Q4 2019 | share | Decrease | -2.40% | -715 shares | 122K | $47.17 | 29.08K |
| Q3 2019 | share | Decrease | -4.73% | -1.48K shares | 37K | $42.17 | 29.79K |
| Q2 2019 | share | Decrease | -2.95% | -950 shares | -12K | $38.66 | 31.27K |
| Q1 2019 | share | Increase | +0.30% | 95 shares | 83K | $37.87 | 32.22K |
| Q4 2018 | share | Decrease | -6.44% | -2.21K shares | -139K | $34.78 | 32.13K |
| Q3 2018 | share | Decrease | -0.33% | -115 shares | 149K | $36.23 | 34.34K |
| Q2 2018 | share | Decrease | -3.82% | -1.37K shares | -43K | $31.79 | 34.46K |
| Q1 2018 | share | Increase | +8.71% | 2.87K shares | 109K | $31.66 | 35.83K |
| Q4 2017 | share | 0.00% | 0 shares | 27K | $30.56 | 32.96K | |
| Q3 2017 | share | Decrease | -0.83% | -275 shares | -16K | $29.84 | 32.96K |
| Q2 2017 | share | Increase | +0.86% | 285 shares | 107K | $29.58 | 33.23K |
| Q1 2017 | share | Increase | +3.79% | 1.20K shares | 158.67K | $27.02 | 32.95K |
| Q4 2016 | share | Decrease | -1.91% | -618 shares | -196.67K | $22.97 | 31.74K |
| Q3 2016 | share | Decrease | -1.95% | -645 shares | 67K | $27.63 | 32.36K |
| Q2 2016 | share | Decrease | -1.93% | -650 shares | 49K | $25.05 | 33.01K |
| Q1 2016 | share | Decrease | -1.12% | -380 shares | -208K | $23.37 | 33.66K |